Kim J, Villar Z, Jobe O, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, O'Connell RJ, Ake JA, Vasan S, Rao VB, Rao M. Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1. Virology. 2024 Sep;597:110158. doi: 10.1016/j.virol.2024.110158. Epub 2024 Jun 21. PMID: 38941746.
Esber AL, Colt S, Jian N, Dear N, Slike B, Sing'oei V, Maswai J, Iroezindu M, Bahemana E, Kibuuka H, Polyak CS, Streeck H, Shah N, Crowell TA, Ake JA; AFRICOS Study Group. Persistent low-level viraemia is associated with non-infectious comorbidities in an observational cohort in four African countries. J Int AIDS Soc. 2024 Aug;27(8):e26316. doi: 10.1002/jia2.26316. PMID: 39189824.
Avelino-Silva VI, Stone M, Bakkour S, Di Germanio C, Schmidt M, Conway AL, Wright D, Grebe E, Custer B, Kleinman SH, Deng X, Lingappa JR, Defechereux P, Mehrotra M, Grant RM, Vasan S, Facente S, Phanuphak N, Sacdalan C, Akapirat S, de Souza M, Busch MP, Norris PJ; NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P). Suppressed HIV antibody responses following exposure to antiretrovirals - evidence from PrEP randomized trials and early antiretroviral treatment initiation studies. Int J Infect Dis. 2024 Aug 24:107222. doi: 10.1016/j.ijid.2024.107222. Online ahead of print. PMID: 39186969.
Nelson GW, van Duijn J, Yuki Y, Pau MG, Tomaka F, Lavreys L, DeRosa SC, McElrath MJ, Kirk GD, Michael NL, Haas DW, Deeks SG, Wolinsky S, Walker B, Barouch DH, Stieh D, Carrington M. Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles. J Virol. 2024 Aug 20;98(8):e0028124. doi: 10.1128/jvi.00281-24. Epub 2024 Jul 24. PMID: 39046263.
Murray SM, Wiginton JM, Xue QL, Dibble K, Sanchez T, Kane JC, Augustinavicius J, Nowak RG, Crowell TA, Njindam IM, Tamoufe U, Charurat M, Turpin G, Sithole B, Mothopeng T, Nemande S, Simplice A, Kouanda S, Diouf D, Lyons C, Baral S. Measuring sexual behavior stigma among cisgender men who have sex with men: an assessment of cross-country measurement invariance. Stigma Health. 2024 Aug;9(3):349-361. doi: 10.1037/sah0000443. Epub 2023 May 4. PMID: 39185350.
Gubser C, Pascoe RD, Trautmann L, Rasmussen TA, Lewin SR. Protocol for measuring killing capacity and intracellular cytokine production of human HIV antigen-specific CD8 T cells using flow cytometry. STAR Protoc. 2024 Aug 7;5(3):103231. doi: 10.1016/j.xpro.2024.103231. Online ahead of print. PMID: 39116199.
Carpenter D, Hast M, Buono N, Hrapcak S, Sato K, Mrina R, Cox MH, Agaba PA, Vrazo AC, Wolf H, Rivadeneira ED, Shang JD, Mayer MM, Prao AH, Longuma HO, Kabwe C, Lwana PN, Tilahun T, Ts'oeu M, Mutisya I, Omoto LN, Cowan JG, Deus MIJT, Fagbamigbe OJ, Ene U, Ikpeazu A, Ndlovu MB, Matiko E, Schaad N, Bisimba J, Lema E, Musokotwane K, Maphosa T, Buthelezi B, Olarinoye A, Lawal I, Mukungunugwa S, Mwambona JT, Wondimu T, Kathure IA, Igboelina OD, Nzima VN, Bissai RG, Lenka M, Shasha W, Olivier NK, Matsinhe M, Wate A, Godfrey L, Alexander H, Alemnji G, Lecher S. Pediatric and adolescent HIV viral load coverage and suppression rates in the context of the COVID-19 pandemic in 12 PEPFAR-supported sub-Saharan African countries in 2019 and 2020. PLOS Glob Public Health. 2024 Aug 1;4(8):e0003513. doi: 10.1371/journal.pgph.0003513. eCollection 2024. PMID: 39088480.
Hakre S, Sanders-Buell E, Casimier RO, O'Sullivan AM, Peel SA, Tovanabutra S, Scott PT, Okulicz JF. Prevalence of Mycoplasma genitalium Infection and Macrolide and Fluoroquinolone Resistance Mutations Among US Air Force Service Members With HIV, 2016-2020. Open Forum Infect Dis. 2024 Jul 15;11(7):ofae407. doi: 10.1093/ofid/ofae407. eCollection 2024 Jul. PMID: 39077051.
Abucayon EG, Belikow-Crovetto I, Hussin E, Kim J, Matyas GR, Rao M, Alving CR. Water-Soluble and Freezable Aluminum Salt Vaccine Adjuvant. Vaccines (Basel). 2024 Jun 19;12(6):681. doi: 10.3390/vaccines12060681. PMID: 38932410.
Mdluli T, Slike BM, Curtis DJ, Shubin Z, Tran U, Li Y, Dussupt V, Mendez-Rivera L, Pinyakorn S, Stieh DJ, Tomaka FL, Schuitemaker H, Pau MG, Colby DJ, Kroon E, Sacdalan C, de Souza M, Phanupak N, Hsu DC, Ananworanich J, Ake JA, Trautmann L, Vasan S, Robb ML, Krebs SJ, Paquin-Proulx D, Rolland M. Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption. Cell Rep. 2024 Jun 7;43(6):114344. doi: 10.1016/j.celrep.2024.114344. Online ahead of print. PMID: 38850529.
Holroyd KB, Han WM, Apornpong T, Trautmann L, Gatechompol S, Hiransuthikul A, Ubolyam S, Sacdalan C, Sriplienchan S, Kanaprach R, Kerr S, Avihingsanon A, Spudich S, Chan P. Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART. HIV Med. 2024 Jun;25(6):725-736. doi: 10.1111/hiv.13621. Epub 2024 Feb 21. PMID: 38383057.
Julg B, Stephenson KE, Tomaka F, Walsh SR, Sabrina Tan C, Lavreys L, Sarnecki M, Ansel JL, Kanjilal DG, Jaegle K, Speidel T, Nkolola JP, Borducchi EN, Braams E, Pattacini L, Burgess E, Ilan S, Bartsch Y, Yanosick KE, Seaman MS, Stieh DJ, van Duijn J, Willems W, Robb ML, Michael NL, Walker BD, Pau MG, Schuitemaker H, Barouch DH. Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy. NPJ Vaccines. 2024 May 23;9(1):89. doi: 10.1038/s41541-024-00876-2. PMID: 38782902.
Hearps AC, Zhou J, Agius PA, Ha P, Lee S, Price P, Kek H, Kroon E, Akapirat S, Pinyakorn S, Phanuphak N, Sacdalan C, Hsu D, Ananworanich J, Vasan S, Schuetz A, Jaworowski A; SEARCH010/RV254 and SEARCH013/RV304 Study Teams. Adaptive NK Cells Rapidly Expand during Acute HIV Infection and Persist Despite Early Initiation of Antiretroviral Therapy. J Immunol. 2024 May 15;212(10):1553-1563. doi: 10.4049/jimmunol.2300523. PMID: 38558245.
Bai H, Lewitus E, Li Y, Thomas PV, Zemil M, Merbah M, Peterson CE, Thuraisamy T, Rees PA, Hajduczki A, Dussupt V, Slike B, Mendez-Rivera L, Schmid A, Kavusak E, Rao M, Smith G, Frey J, Sims A, Wieczorek L, Polonis V, Krebs SJ, Ake JA, Vasan S, Bolton DL, Joyce MG, Townsley S, Rolland M. Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding. Nat Commun. 2024 May 9;15(1):3924. doi: 10.1038/s41467-024-48139-x. PMID: 38724518.
Vasireddy V, Brown NE, Shah N, Crowell TA. Sustaining HIV service delivery to key population clients using client-centered models during the debate and enactment of the Anti-Homosexuality Act in Uganda. J Int AIDS Soc. 2024 May;27(5):e26253. doi: 10.1002/jia2.26253. PMID: 38712676.
Oboho IK, Esber AL, Dear N, Paulin HN, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Shah N, Crowell TA, Ake JA, Polyak CS; AFRICOS Study Group. Advanced HIV disease in East Africa and Nigeria, in The African Cohort Study. J Acquir Immune Defic Syndr. 2024 May 1;96(1):51-60. doi: 10.1097/QAI.0000000000003392. Epub 2024 Apr 10. PMID: 38427929.
Romo ML, Moreland SC, Yates AM, Crowell TA, Sevilla M, MacArthur JL, Faestel P, Kunz A, Ake JA, Calvano T, Colby DJ. Prevalence of Urogenital Mycoplasma genitalium Infection at 2 US Army Medical Facilities. Sex Transm Dis. 2024 May 1;51(5):367-373. doi: 10.1097/OLQ.0000000000001947. Epub 2024 Feb 10. PMID: 38346403.
Abucayon EG, Sweeney S, Matyas GR. A Reliable Quantification of Cholesterol and 25-Hydroxycholesterol in Liposomal Adjuvant Formulation by Liquid Chromatography High-Resolution Tandem Mass Spectrometry. ACS Omega. 2024 Apr 17;9(17):19637-19644. doi: 10.1021/acsomega.4c01524. eCollection 2024 Apr 30. PMID: 38708252.
Bakri FG, Mukattash HH, Esmeiran H, Schluck G, Storme CK, Broach E, Mebrahtu T, Alhawarat M, Valencia-Ruiz A, M'Hamdi O, Malia JA, Hassen Z, Shafei MMS, Alkhatib AY, Gazo M, Jaradat SA, Gomez Y, McGeehon S, McCauley MD, Moreland SC, Darden JM, Amare M, Crowell TA, Vasan S, Michael NL, Ake JA, Modjarrad K, Scott PT, Peel SA, Hakre S; RV505 study group. Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: a national study. Int J Infect Dis. 2024 Apr 30:107079. doi: 10.1016/j.ijid.2024.107079. Online ahead of print. PMID: 38697607.
Adeyemi OA, Nowak RG, Morgan D, Sam-Agudu NA, Craddock J, Zhan M, Crowell TA, Baral S, Adebajo S, Charurat ME; TRUST/RV368 Study Group. Risk Compensation After Initiation of Daily Oral Pre-exposure Prophylaxis Among Sexual and Gender Minorities in Nigeria. Arch Sex Behav. 2024 Apr 29. doi: 10.1007/s10508-024-02859-9. Online ahead of print. PMID: 38684621.
Mwesigwa B, Sawe F, Oyieko J, Mwakisisile J, Viegas E, Akintunde GA, Kosgei J, Kokogho A, Ntinginya N, Jani I, Shukarev G, Hooper JW, Kwilas SA, Ward LA, Rusnak J, Bounds C, Overman R, Badorrek CS, Eller LA, Eller MA, Polyak CS, Moodley A, Tran CL, Costanzo MC, Leggat DJ, Paquin-Proulx D, Naluyima P, Nkafu Anumendem D, Gaddah A, Luhn K, Hendriks J, McLean C, Douoguih M, Kibuuka H, Robb ML, Robinson C, Ake JA. Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa. Clin Infect Dis. 2024 Apr 24:ciae215. doi: 10.1093/cid/ciae215. Online ahead of print. PMID: 38657084.
Jain S, Uritskiy G, Mahalingam M, Batra H, Chand S, Trinh HV, Beck C, Shin WH, Alsalmi W, Kijak G, Eller LA, Kim J, Kihara D, Tovanabutra S, Ferrari G, Robb ML, Rao M, Rao VB. A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1. Elife. 2024 Apr 15;13:RP92379. doi: 10.7554/eLife.92379. PMID: 38619110.
Kemp CG, Pence BW, Velloza J, Concepcion T, Moitra M, Iroezindu M, Bahemana E, Kibuuka H, Semwogerere M, Owuoth J, Maswai J, Langat R, Esber AL, Dear NF, Parikh A, Crowell TA, Ake JA, Polyak CS, Collins PY; AFRICOS Study Group. Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda. AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891. Online ahead of print. PMID: 38507586.
Rwabiyago OE, Katale A, Bingham T, Grund JM, Machangu O, Medley A, Nkomela ZM, Kayange A, King'ori GN, Juma JM, Ismail A, Kategile U, Akom E, Mlole NT, Schaad N, Maokola W, Nyagonde N, Magesa D, Kazitanga JC, Maruyama H, Temu F, Kimambo S, Sando D, Mbatia R, Chalamila ST, Ogwang BE, Njelekela MA, Kazaura K, Wong VJ, Gongo R, Njau PF, Mbunda A, Nondi J, Bateganya M, Greene J, Breda M, Mgomella G, Rwebembera A, Swaminathan M. Social network strategy (SNS) for HIV testing: a new approach for identifying individuals with undiagnosed HIV infection in Tanzania. AIDS Care. 2024 Mar 19:1-10. doi: 10.1080/09540121.2024.2307383. Online ahead of print. PMID: 38502602.
VanderVeen LA, Selzer L, Moldt B, Parvangada A, Li J, Ananworanich J, Crowell TA, Eron JJ, Daar ES, Haubrich R, Geleziunas R, Cyktor J, Mellors JW, Callebaut C. HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection. AIDS. 2024 Mar 15;38(4):607-610. doi: 10.1097/QAD.0000000000003792. Epub 2023 Nov 16. PMID: 38416554.
Chan P, Moreland S, Sacdalan C, Kroon E, Colby D, Sriplienchan S, Pinyakorn S, Phanuphak N, Jagodzinski L, Valcour V, Vasan S, Paul R, Trautmann L, Spudich S; RV254/SEARCH 010 Study Team. Cerebrospinal fluid pleocytosis is associated with HIV-1 neuroinvasion during acute infection. AIDS. 2024 Mar 1;38(3):373-378. doi: 10.1097/QAD.0000000000003777. Epub 2023 Nov 22. PMID: 37916464.
Holroyd KB, Han WM, Apornpong T, Trautmann L, Gatechompol S, Hiransuthikul A, Ubolyam S, Sacdalan C, Sriplienchan S, Kanaprach R, Kerr S, Avihingsanon A, Spudich S, Chan P. Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART. HIV Med. 2024 Feb 21. doi: 10.1111/hiv.13621. Online ahead of print. PMID: 38383057.
Shafieichaharberoud F, Lang S, Whalen C, Rivera Quiles C, Purcell L, Talbot C, Wang P, Norton EB, Mazei-Robison M, Sulima A, Jacobson AE, Rice KC, Matyas GR, Huang X. Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like Particles. Bioconjug Chem. 2024 Feb 21;35(2):164-173. doi: 10.1021/acs.bioconjchem.3c00415. Epub 2023 Dec 19. PMID: 38113481.
Kim IJ, Gonzalez O, Tighe MP, Lanthier PA, Clark MJ, Travis KL, Low-Beer TC, Lanzer KG, Bernacki DT, Szaba FM, De La Barrera RA, Dussupt V, Mendez-Rivera L, Krebs SJ, Ross CN, Mdaki SD, Brasky KM, Layne-Colon D, Tardif SD, Thomas SJ, Modjarrad K, Blackman MA, Patterson JL. Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets. NPJ Vaccines. 2024 Feb 17;9(1):35. doi: 10.1038/s41541-024-00824-0. PMID: 38368443.
Kim IJ, Tighe MP, Lanthier PA, Clark MJ, De La Barrera RA, Dussupt V, Mendez-Rivera L, Krebs SJ, Travis KL, Low-Beer TC, Cookenham TS, Lanzer KG, Bernacki DT, Szaba FM, Schneck AA, Ward J, Thomas SJ, Modjarrad K, Blackman MA. Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice. NPJ Vaccines. 2024 Feb 15;9(1):32. doi: 10.1038/s41541-024-00823-1. PMID: 38360793.
N'guessan KF, Machmach K, Swafford I, Costanzo MC, Wieczorek L, Kim D, Akapirat S, Polonis VR, Pitisuttithum P, Nitayaphan S, Gurunathan S, Sinangil F, Chariyalertsak S, Ake JA, O'connell RJ, Vasan S, Paquin-Proulx D. Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production. Front Immunol. 2024 Feb 13;15:1339727. doi: 10.3389/fimmu.2024.1339727. eCollection 2024. PMID: 38420129.
Romo ML, Moreland SC, Yates AM, Crowell TA, Sevilla M, MacArthur JL, Faestel P, Kunz A, Ake JA, Calvano T, Colby DJ. Prevalence of urogenital Mycoplasma genitalium infection at two US Army medical facilities. Sex Transm Dis. 2024 Feb 12. doi: 10.1097/OLQ.0000000000001947. Online ahead of print. PMID: 38346403.
Lewitus E, Li Y, Bai H, Pham P, Rolland M. HIV-1 Gag, Pol, and Env diversified with limited adaptation since the 1980s. mBio. 2024 Feb 8:e0174923. doi: 10.1128/mbio.01749-23. Online ahead of print. PMID: 38329340.
Sankhala RS, Dussupt V, Chen WH, Bai H, Martinez EJ, Jensen JL, Rees PA, Hajduczki A, Chang WC, Choe M, Yan L, Sterling SL, Swafford I, Kuklis C, Soman S, King J, Corbitt C, Zemil M, Peterson CE, Mendez-Rivera L, Townsley SM, Donofrio GC, Lal KG, Tran U, Green EC, Smith C, de Val N, Laing ED, Broder CC, Currier JR, Gromowski GD, Wieczorek L, Rolland M, Paquin-Proulx D, van Dyk D, Britton Z, Rajan S, Loo YM, McTamney PM, Esser MT, Polonis VR, Michael NL, Krebs SJ, Modjarrad K, Joyce MG. Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain. Structure. 2024 Feb 1;32(2):131-147.e7. doi: 10.1016/j.str.2023.11.015. Epub 2023 Dec 28. PMID: 38157856.
Chacha S, Hui J, Yuxin T, Ziping W, Yan H, Ali S, Abeid W, Dominick W, Malimu E, Emanuel F, Saidi S, Lyimo D, Mwanyika V, Kumalija E, Dang S. Associated factors of malnutrition status among children and adolescents living with HIV in Tanzania: Individual-level analysis and marginal effect estimation. Int J STD AIDS. 2024 Feb;35(2):136-146. doi: 10.1177/09564624231210932. Epub 2023 Nov 1.PMID: 37909163
Juraska M, Bai H, deCamp AC, Magaret CA, Li L, Gillespie K, Carpp LN, Giorgi EE, Ludwig J, Molitor C, Hudson A, Williamson BD, Espy N, Simpkins B, Rudnicki E, Shao D, Rossenkhan R, Edlefsen PT, Westfall DH, Deng W, Chen L, Zhao H, Bhattacharya T, Pankow A, Murrell B, Yssel A, Matten D, York T, Beaume N, Gwashu-Nyangiwe A, Ndabambi N, Thebus R, Karuna ST, Morris L, Montefiori DC, Hural JA, Cohen MS, Corey L, Rolland M, Gilbert PB, Williamson C, Mullins JI. Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features. Proc Natl Acad Sci U S A. 2024 Jan 23;121(4):e2308942121. doi: 10.1073/pnas.2308942121. Epub 2024 Jan 19. PMID: 38241441.
Viard M, O'hUigin C, Yuki Y, Bashirova AA, Collins DR, Urbach JM, Wolinsky S, Buchbinder S, Kirk GD, Goedert JJ, Michael NL, Haas DW, Deeks SG, Walker BD, Yu X, Carrington M. Impact of HLA class I functional divergence on HIV control. Science. 2024 Jan 19;383(6680):319-325. doi: 10.1126/science.adk0777. Epub 2024 Jan 18. PMID: 38236978.
Sankhala RS, Lal KG, Jensen JL, Dussupt V, Mendez-Rivera L, Bai H, Wieczorek L, Mayer SV, Zemil M, Wagner DA, Townsley SM, Hajduczki A, Chang WC, Chen WH, Donofrio GC, Jian N, King HAD, Lorang CG, Martinez EJ, Rees PA, Peterson CE, Schmidt F, Hart TJ, Duso DK, Kummer LW, Casey SP, Williams JK, Kannan S, Slike BM, Smith L, Swafford I, Thomas PV, Tran U, Currier JR, Bolton DL, Davidson E, Doranz BJ, Hatziioannou T, Bieniasz PD, Paquin-Proulx D, Reiley WW, Rolland M, Sullivan NJ, Vasan S, Collins ND, Modjarrad K, Gromowski GD, Polonis VR, Michael NL, Krebs SJ, Joyce MG. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques. Nat Commun. 2024 Jan 3;15(1):200. doi: 10.1038/s41467-023-44265-0. PMID: 38172512.
Prabhakaran M, Matassoli F, Leggat D, Hoover A, Srikanth A, Wu W, Henry AR, Wang J, Lin BC, Teng IT, Schramm CA, Castro M, Serebryannyy L, Jean-Baptiste N, Moore C, Gajjala S, Todd JM, McCarthy E, Narpala S, Francica J, Program VP, Corbett-Helaire KS, Douek DC, Kwong PD, Seder RA, Andrews SF, McDermott AB. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates. Sci Transl Med. 2024 Jan 3;16(728):eadd5960. doi: 10.1126/scitranslmed.add5960. Epub 2024 Jan 3. PMID: 38170789.
Sing'oei V, Nwoga C, Yates A, Owuoth J, Otieno J, Broach E, Li Q, Hassen Z, Imbach M, Milazzo M, Mebrahtu T, Robb ML, Ake JA, Polyak CS, Crowell TA; RV393 Study Group. HIV prevalence and awareness among adults presenting for enrolment into a study of people at risk for HIV in Kisumu County, Western Kenya. PLoS One. 2024 Jan 2;19(1):e0294860. doi: 10.1371/journal.pone.0294860. eCollection 2024.PMID: 38166089
Albalawi YA, Shull T, Virdi AK, Subra C, Mitchell J, Slike BM, Jian N, Krebs SJ, Sacdalan C, Ratnaratorn N, Hsu DC, Phanuphak N, Spudich S, Trautmann L, Al-Harthi L. CD4 dim CD8 bright T cells are inversely associated with neuro-inflammatory markers among people with HIV. AIDS. 2024 Jan 1;38(1):1-7. doi: 10.1097/QAD.0000000000003743. Epub 2023 Oct 3. PMID: 37792358.